Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines.
Neoplasma. 2004;51(5):358-67.
Neoplasma. 2004.
PMID: 15640940
The significance of key regulators of apoptosis in the development and prognosis of prostate carcinoma. I. Proteins of the Bcl-2 family and protein p53.
Knillová J, Kolár Z.
Knillová J, et al.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003 Nov;147(1):3-10.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003.
PMID: 15034599
Review.
Item in Clipboard
The significance of key regulators of apoptosis in the development and prognosis of prostate carcinoma. II. Products of suppressor genes Rb and PTEN, CDKI, Fas.
Knillová J, Kolár Z, Hlobilková A.
Knillová J, et al.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003 Nov;147(1):11-7. doi: 10.5507/bp.2003.002.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003.
PMID: 15034600
Review.
Item in Clipboard
The mechanism of action of the tumour suppressor gene PTEN.
Hlobilková A, Knillová J, Bártek J, Lukás J, Kolár Z.
Hlobilková A, et al. Among authors: knillova j.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003 Nov;147(1):19-25.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003.
PMID: 15034601
Review.
Item in Clipboard
Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.
Hlobilkova A, Knillova J, Svachova M, Skypalova P, Krystof V, Kolar Z.
Hlobilkova A, et al. Among authors: knillova j.
Anticancer Res. 2006 Mar-Apr;26(2A):1015-22.
Anticancer Res. 2006.
PMID: 16619501
Free article.
Item in Clipboard
The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy.
Huskova Z, Knillova J, Kolar Z, Vrbkova J, Kral M, Bouchal J.
Huskova Z, et al. Among authors: knillova j.
Biomedicines. 2020 Jun 25;8(6):173. doi: 10.3390/biomedicines8060173.
Biomedicines. 2020.
PMID: 32630458
Free PMC article.
Item in Clipboard
Cite
Cite